They’ll be out in early 2019.

THQ Nordic has announced that three games – The Book of Unwritten Tales 2, The Raven Remastered, and Sphinx and the Cursed Mummy – will be arriving on the Nintendo Switch in 2019.

The first title, The Book of Unwritten Tales 2, allows you to take control of four different characters in a playful, point-and-click adventure, based in a fantasy world.

The game was first released back in 2015 (you can have a read of our review here) and the trailer, which you can check out below, gives us a glimpse into its colourful world. The game promises over 20 hours of gameplay, humour packed with references to many popular fantasy worlds, and a whole bunch of crazy “but surprisingly logical” puzzles.

The second game is The Raven Remastered. The original game was released in 2013, with the Remastered title arriving earlier this year.

King Arts’s point-and-click adventure finds you in London, circa 1964, as Constable Anton Jakob Zellner tries to solve a murder-mystery where nothing is as it seems. The game will have you experiencing the story from the viewpoint of several characters while taking you to classic mystery locations, such as a train in the Swiss Alps, a majestic cruise ship, and the Cairo Museum.

You can check out the trailer, below.

The final game, Sphinx and the Cursed Mummy, is an action-adventure inspired by ancient Egypt. Sphinx, aided by his friend The Mummy, will have to stop Set by finding the stolen crowns of Egypt. As well as using Sphinx’s weapons skills to take down deadly monsters, you’ll be able to take control of the Mummy and use stealth to avoid detection.

Sphinx and the Cursed Mummy was first released back in 2003 and it was brought to PC last year. A Switch specific trailer hasn’t been released for this one yet but you can check out the launch trailer for the PC version, below.

All three games will be available digitally and in retail stores, with the RRP set to £26.99/€29.99/ $29.99 for each.

We’ll let you know when a more specific release date has been confirmed.